Dr. Koushik Kumar Das, MD

Dr. Das practices at Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health.

Dr. Das' NPI, 1023245859, was assigned on June 19, 2009. Dr. Das graduated from Vagelos College of Physicians and Surgeons in 2009. Dr. Das holds Missouri license 2016013228.

Dr. Das' primary practice is Missouri Baptist Medical Center, at 3015 N Ballas Rd, Saint Louis, MO 63131 in St. Louis County. The practice phone is (314) 996-5000.

Dr. Das' primary practice is Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health. Dr. Das is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Das to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Das practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Das' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Das is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Das' licenses on file in 3 states: Missouri, Illinois and Pennsylvania.

Dmand AI lists acid reflux, colonoscopy, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Das treats.

CMS data shows 551 Medicare services from Dr. Das across 15 procedure codes in 2024, for 332 Medicare patients. Medicare paid $66,185 for them.

CMS counts 332 Medicare patients who saw Dr. Das in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Das' median patient age at 68, with 56% women.

In 2024, Dr. Das wrote 359 Medicare Part D claims for 211 patients. 82% of them were for generic drugs. CMS names the drug for 316 of them, across 9 drugs with 11 or more claims each, at $35,889 in total drug cost. In 2023, CMS named 260 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Das for performance year 2024, reported as part of a group. Dr. Das accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 401 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Das, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 67 papers to Dr. Das, published from 2009 to 2025. 2018 was the busiest year, with 13. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Cholangiopancreatography, Endoscopic Retrograde. Dr. Das has published most often in Gastrointest Endosc. Dr. Das' most frequent co-authors are Vladimir Markovicl Kushnir, MD, Gabriel David Lang, MD and Daniel Kast Mullady, MD.

Dmand AI links Dr. Das to 4 clinical trials. 3 are still active or recruiting. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Barrett Esophagus. Washington University School of Medicine sponsors the most, 3.

CMS Open Payments shows 101 general payments to Dr. Das from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 41% of the total. Olympus America Inc. paid the most, $18,750.

Dr. Das graduated from Vagelos College of Physicians and Surgeons in 2009.

Dr. Das is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.